logo-loader
viewTissue Regenix Group PLC

Tissue Regenix CFO Paul Devlin to step down

Paul Devlin played a "significant role" throughout the group's fundraise used for the acquisition of CellRight Technologies

Tissue Regenix
The regenerative medical device company has seen some big changes at the top

Tissue Regenix Group PLC (LON:TRX) said on Friday that chief financial officer Paul Devlin will step down and the medical device company has started the process to appoint a successor.

Steve Couldwell, who was named as chief executive in November, said: "Paul played a significant role throughout the fundraise and acquisition process, we wish him every success in the future."

READ: Tissue Regenix appoints non-executive director Couldwell as new chief executive

In August, Tissue raised £40mln from investors, of which £25mln was used to complete the “transformational” acquisition of CellRight Technologies.

Alongside the announcement of Devlin’s departure, the company said it has issued and allotted 552,337 ordinary shares of 0.5p each following the exercise of options.

Quick facts: Tissue Regenix Group PLC

Price: 0.375 GBX

AIM:TRX
Market: AIM
Market Cap: £4.39 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tissue Regenix increasing throughput in its facility to meet 'exceptional...

Tissue Regenix PLC's (LON:TRX) Gareth Jones caught up with Proactive's Andrew Scott to update on developments in the regenerative medical devices maker's second half. ''The focus is really on increasing throughput in our San Antonia facility in the United States to allow us to meet the demand...

on 19/12/19

2 min read